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ABSTRACT 
 
 
 
 
In Malaysia, the number of dialysis patient keeps increasing every year with 
an estimation of 5,000 new cases of end-stage kidney failure (ESRD) each year. Thus, 
the development of an efficient haemodialyser is crucial to meet this demand. The 
objective of this research is to develop a biocompatible asymmetric, ultrafiltration 
hollow fibre membrane (HFM) for haemodialysis application. Polyethersulfone (PES) 
was chosen as the main polymer in the fabrication of the haemodialysis HFM due to 
its outstanding oxidative, thermal and hydrolytic stability as well as good mechanical 
and film-forming properties. Polyurethane (PU) heparin like structure (range of 0-
5wt%) was used as additive in the PES HFM to improve blood compatibility of PES 
HFM. The HFM of blended PES/PU was fabricated using a dry/wet inversion phase 
spinning technique and its properties was characterised using a number of physico-
chemical analyses and in-vitro blood compatibility tests. For the physico-chemical 
analyses, each of the membrane fabricated showed the desired asymmetry structure, 
dense area in the inner surface near the lumen and finger-like structure near the end of 
the outer membrane. The pore size of the membrane is in good agreement with the 
morphology and the surface roughness of the membrane. A high amount of PU in the 
membrane resulted in more porous finger-like pore structure, smoother surface, higher 
hydrophilicity and higher pore size. Based on the in-vitro biocompatibility analysis of 
the membrane, it is proposed that the membrane incorporated with PU has better 
anticoagulant properties compared to the control sample. PU incorporation prolonged 
the clotting time, decreased the formation of thrombin, decreased soluble C3a 
generation and suppressed platelet adhesion and aggregation. The anionic groups on 
the membrane surface might bind to coagulation factors (antithrombin) and thus 
improve anticoagulant ability. Based on both physico-chemical and in-vitro results, 
4% loading of PU is the optimum loading for incorporation with PES HFM. The results 
suggested that the blended PES-PU membranes with good haemocompatibility should 
be applied in the field of blood purification during haemodialysis process. 
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ABSTRAK 
 
 
 
 
Di Malaysia, bilangan pesakit yang mengalami kegagalan buah 
pinggang peringkat akhir (ESRD) semakin meningkat dengan anggaran 5000 pesakit 
yang didiagnosis positif ESRD setiap tahun. Justeru, pembangunan membran dialisis 
yang efisien adalah sangat kritikal untuk menampung permintaan ini. Objektif kajian 
ini adalah untuk membangunkan membran gentian geronggang tidak simetri kultra 
turasan untuk aplikasi hemodialisis. Polietersulfon (PES) telah dipilih untuk menjadi 
bahan polimer yang utama dalam pembentukan membran hemodialisis kerana 
mempunyai ciri oksidatif yang unggul, haba dan hidrolitik yang stabil serta 
mempunyai ciri mekanikal yang baik dan mampu menghasilkan lapisan nipis.  
Poliuritan (PU) yang mempunyai ciri-ciri seperti heparin akan disintesis dalam 
lingkungan 0-5wt% telah digunakan sebagai bahan tambahan dalam PES HFM untuk 
meningkatkan keserasian darah PES HFM Membran gentian geronggang PES/PU 
telah dihasilkan melalui proses pembentukan kaedah pemintalan kering/basah dan 
sifat-sifatnya dicirikan dengan menggunakan beberapa analisis fiziko-kimia dan in-
vitro ujian keserasian darah. Bagi analisis fiziko-kimia, setiap membran yang terhasil 
menunjukkan ciri-ciri yang dikehendaki iaitu, struktur tidak simetri, kawasan padat di 
permukaan yang berdekatan lumen dan struktur jejari di bahagian luar membran. Saiz 
liang membran juga sekata dengan morfologi dan permukaan kasar membran. 
Kandungan PU yang lebih tinggi di dalam membran menghasilkan struktur membran 
yang mempunyai lebih banyak liang, permukaan yang lebih licin dan lebih hidrofilik 
dan saiz liang yang lebih besar. Berdasarkan keputusan dari keserasian membran 
dengan darah secara in-vitro, membran yang telah diubahsuai dengan PU mempunyai 
ciri-ciri penggumpalan yang lebih baik berbanding dengan sampel kawalan. PU ini 
juga mempunyai masa pembekuan yang lebih lama, mengurangkan pembentukan 
trombin, mengurangkan generasi C3a, dan menghalang lekatan platelet. Kumpulan 
anionik di permukaan membran mungkin mengikat kepada faktor-faktor pembekuan 
(antithrombin) dan dengan itu meningkatkan keupayaan antikoagulan. Berdasarkan 
keputusan fiziko-kimia dan keserasian membran dengan darah secara in-vitro, 4wt% 
kandungan PU yang dicampurkan dengan PES adalah campuran yang paling ideal. 
Dapatan kajian menunjukkan bahawa campuran membran PES-PU dengan 
haemocompatibility mempunyai sifat keserasian yang baik dan seterusnya 
membenarkan permohonan praktikal dalam bidang pembersihan darah semasa proses 
hemodialisis.  
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CHAPTER 1  
INTRODUCTION 
1.1 Research Background 
 
 
In recent years, there has been a crucial rise of kidney failure notably chronic 
kidney disease (CKD) caused by disease or condition impairs kidney function, causing 
kidney damage to worsen over several months or years as reported by National Kidney 
Foundation Malaysia (Yam et al., 2016). The recent statistic from National Kidney 
Foundation Malaysia reveals worrying figures where the total number of 
haemodialysis patients increases from 12,182 patients in year 2005 to 31,497 patients 
in year 2014 (Table 1.1). Renal patients need to undergo this treatment for 3 to 4 hours 
at least three times a week (Hakim et al., 2016). This treatment could be burden in term 
of finance especially to the people from middle class and poor background. Resulting 
in the urge to search for better and more efficient and low cost ultrafiltration system. 
 
 
Table 1.1 Stock and flow of renal replacement therapy in Malaysia from year 
2005-2014 (Yam et al., 2016) 
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
New dialysis patients 3,167 3,709 4,103 4,640 4,952 5,305 6,073 6,690 6,985 7,055 
New transplants 172 151 112 131 141 128 127 107 98 81 
Dialysis deaths 1,515 1,820 1,987 2,191 2,601 3,047 3,292 3,645 4,001 4,015 
Transplant deaths 49 58 47 59 49 48 55 64 56 45 
Dialysing at 31st 
December 
13,356 15,080 17,084 19,388 21,590 23,709 26,328 29,223 32,026 34,767 
Functioning transplant 
at 31st December 
1,716 1,771 1,788 1,808 1,852 1,881 1,907 1,891 1,870 1,844 
 
 
2 
 
 
 
Haemodialysis is one of the prominent treatments for chronic kidney disease 
(CKD) and end stage renal disease (ESRD). Haemodialysis helps to filtrate out low 
and middle molecular weight uremic toxins from the blood and helps to balance the 
pH value in the body. Barzin et al. (2004) stated that uremic toxins such as urea and 
creatinine range from size 10,000-55,000 Da needs to be excreted out from the blood, 
while, proteins such as albumin (66,000 Da) need to be retained. In order for these 
secretion and retention to be worked, the design of the membrane needs to fulfil certain 
criteria. The membrane produced is preferred to be high flux, asymmetric, micro 
porous ultrafiltration hollow fibre membrane.  
 
 
One of the most important components in blood purification application that 
need to be considered thoroughly is the membrane of the haemodialysis. The 
membrane of the haemodialysis is potted inside a module and is known as 
haemodialyser, which is the heart of the haemodialysis system. The implementation of 
membrane technology in blood purification applications has proven vital. In hollow 
fibre ultrafiltration system, blood purification is achieved by regulating impure blood 
flow through the lumen of hollow fibre membrane as the dialysate flows counter-
currently outside the lumen (Dahe et al., 2011). Uremic toxins like urea, creatinine etc. 
are filtered out from the blood through the porous structure of the membrane. The 
membrane facilitates the filtration without the loss of important blood proteins such as 
albumin (Dahe et al., 2011). Desirable characteristics of such hollow fibre membranes 
include high flux, selectivity and biocompatibility (Clark et al., 2002). However, 
clinical complications such as neutropenia, hypersensitivity reactions, oxidative stress, 
contact and complement activation, have repeatedly associated with the commercially 
available and widely used polysulfone haemodialysis membrane (Urbani et al., 2012). 
This causes the decrease in quality of life, life expectancy and mortality of 
haemodialysis patients and has limited the success rates of such membranes. Thus, the 
selection of membrane used for haemodialysis needs to be chosen wisely in order to 
prevent any bio-incompatibility due to the interaction between blood and the new 
haemodialysis membranes. 
 
 
Functionalisation of polymer membranes has been studied as one of the 
methods to improve polymer properties. The surface of membranes has been modified 
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and grafted using several of functional groups like hydroxyl, ketone and carboxylic 
acid groups. The chemical bonding between substrates and adhesives is able to be 
improved by adding functional groups to the polymer. Through functionalisation 
method, properties such as hydrophilicity, hydrophobicity, biocompatibility, anti-
fouling, and antibacterial properties etc. can be enhanced, while some of membrane 
native properties and its core structure are still remained (Dahe et al., 2011).  
 
 
 
 
1.2 Problem Statement 
 
 
Currently, polysulfone (PSf) and polyethersulfone (PES) are among the most 
available and commercial haemodialysis membranes that have been used as the main 
polymer in the fabrication of asymmetric hollow fibre haemodialysis membrane. 
However, these membranes have been associated with numerous of clinical 
complications which include hypersensitivity reactions, neutropenia, oxidative stress, 
and complement activation.   
 
 
Hydrophobic property of PES membrane is the main disadvantage of this 
polymer. Many studies have concluded that the material hydrophobicity is the causes 
of membrane fouling. Membrane fouling happens when protein adsorbs on the surface 
of the membrane (Khulbe et al., 2010). However, Zhao et al. (2013) has been reported 
the opposite findings. He stated that the adsorption of nonpolar solutes, hydrophobic 
particles or bacteria is the cause of membrane fouling. Membrane fouling is a serious 
problem in membrane filtration, resulting in a higher energy demand, shorter 
membrane lifetime, and unpredictable separation performance (Agenson et al., 2007; 
Su et al, 2011).  The most desirable property of a biomaterial is the biocompatibility 
of the material towards body. Biologically compatible means that in contact of foreign 
material with human body mechanism will not produce a toxic, injurious and 
immunological response in living tissues or blood (Dahe et al., 2011). The most 
commonly accepted mode of improving hollow fibre membranes biocompatibility is 
the modification of surface chemistry. Thus, in order to improve the hydrophilicity of 
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PES hollow fibre membrane used in haemodialysis, PES is modified by hydrophilic 
polymers.  
 
 
Polyurethane (PU) has been reported to be used in blood-contacting application 
due to its excellent mechanical properties and relatively good blood compatibility 
(Agenson et al., 2007; Li et al, 2012). Meanwhile, PU, with a Hansen solubility 
coefficient δt = 20.5 MPa1/2, showed good miscibility with PES (δt = 21.3 MPa1/2), the 
miscibility has also been proved by using the cloud point measurements, and all of 
these showed similar results (Yin et al., 2014). The excellent miscibility ensured a 
homogeneous blend between the PU and the PES, and inhibited the macro phase 
separation. Therefore, the blending of PU would not affect the morphology and the 
surface roughness of the PES membrane significantly.  
 
 
However, limited number of research works has been done on the grafting 
functional group or functional molecules to PU, such as hydroxyl group, carboxyl 
group, and sulphonic group. Therefore, in this study, PU polymerisation and 
sulphonation will be tested, which it is expected that the modified PU could minimise 
protein adsorption and prolong blood coagulation time. The aim of this study is to 
introduce hydroxyl, carboxyl and sulphonic groups onto the molecular chains of PU 
and to synthesize a polyurethane with good blood compatibility, which later on will be 
used for the modification of PES haemodialysis membrane. Positive result will not 
only give benefits to the university but also to the biomaterial field of research. 
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1.3 Research Objectives 
 
 
The general aim of this proposed project is to fabricate a haemocompatible PES based 
hollow fibre membrane for haemodialysis. The specific objectives of this study are: 
 
 
1) To synthesise and functionalise hydrophilic PU heparin like structure as 
biocompatible additive for haemodialysis membrane. 
2) To fabricate and characterise physico-chemical properties of the asymmetric 
PES/PU hollow fibre membrane.  
3) To study the blood compatibility of PES hollow fibre membrane that 
incorporated with modified PU in haemodialysis application. 
 
 
 
 
1.4 Scopes of Study 
 
 
In order to achieve the objective of this research, the following scopes are outlined: - 
 
 
1) Modifying PU molecular structure by first synthesising it from methylene 
diphenyl diisocynate (MDI) and dimethylolpropionic acid (DMPA) at 
temperature 80°C for 6 hours and then functionalising it by sulphonating with 
concentrated H2SO4 for 16 hours. 
2) Determining PU characterisation by analysing the attenuated total reflectance-
fourier transform infrared (ATR-FTIR), nuclear matrix resonance (NMR) and 
matrix assisted laser desorption ionisation time of flight (MALDI-TOF) 
analysis. 
3) Investigating suitable spinning conditions (air gap distance, dope extrusion rate, 
bore fluid flow rate and the take-up speed) to produce an asymmetric, micro 
porous ultrafiltration hollow fibre specifically for haemodialysis membrane. 
4) Preparing a dope solution that, made of different loadings of PU (0-5%wt) in 
PES blended with polyvinylpyrrolidone (PVP) solution.  
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5) Fabricating polymeric hollow fibre membrane via dry/wet spinning technique 
using the preliminary identified spinning parameters (50 cm air gap, 3 cm3/min 
of dope extrusion rate, and 1 cm3/min bore fluid flow rate) and PVP as the pore 
modifier. 
6) Observing the hollow fibre membrane morphology, membrane molecular 
orientation, membrane hydrophobicity/hydrophilicity, membrane porosity and 
thermal transition and stability using scanning electron microscopy (SEM), 
ATR-FTIR, contact angle measurement, zeta-potential and thermagravimetric 
analysis (TGA) test respectively.  
7) Evaluating PES/PU membrane haemocompatibility by assessment in protein 
adsorption, platelet adhesion, thrombogenic properties, coagulation and 
complement activation. 
 
 
 
 
1.4 Significant of the Study 
 
 
Over the past 15 years, the figure of patients experiencing chronic kidney 
diseases has increased dramatically. Such kidney diseases render the incapable of 
kidney to filter and remove body waste from the bloodstream. The most widely 
accepted extracorporeal treatment used to filter and purify blood is haemodialysis. 
According to Malaysia’s National Renal Registry, it has been reported that the total 
number of people underwent haemodialysis had risen from 6689 in 2000 to 21159 in 
2009. The number did not stop there. The latest report dated March 2013 mentioned 
the increase of dialysis patients to 26159 people (Yam et al., 2016).  
 
 
The main component of haemodialysis machine is the dialyser, where a semi-
permeable membrane is used as the filter. As the paramount component for 
haemodialysis system, the development of membrane continues to attain the best of it. 
Due to bio-incompatibility and low performance of cellulose-based membranes, fully 
synthetic membrane was introduced and became favourable until very recent times. 
These synthetic membranes are made up of a variety of hydrophobic polymers as the 
main component to serve as hosts. The rationale and significance of this current 
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research are to explore the formation and development of modified PES hollow fibre 
membranes blended with hydrophilic addictive PU for haemodialysis application. 
Physicochemical properties of PU have been proven to be reliable blood compatible 
biomaterials. Thus the blending of PU with PES is expected to enhance the 
haemocompatibility of the fabricated membrane when contacting with blood.  
 
 
In Malaysia, very few researches on haemodialysis membranes have been 
conducted. There is no large-scale initiative to utilise local expertise in membrane for 
haemodialysis application. Until now, Malaysia is still depending on imported 
dialysers for haemodialysis treatments in either government or private hospitals. The 
information constraint in this field is the main cause of this problem. The impact of 
this matter includes unnecessary expenditure due to high cost of dialysers. Therefore, 
this research’s long-term target is to develop a locally made dialyser equipped with a 
highly efficient membrane in order to sustain current demand especially in Malaysia.   
Furthermore, this research study may lead to a new finding that can possibly be a basis 
for the next move in fabricating high performance haemodialysis membrane. Positive 
result can benefit to the membrane field of research especially in membrane 
technology for haemodialysis application. 
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